An historical overview over Pharmacovigilance

Giulia Fornasier, Sara Francescon, Roberto Leone, Paolo Baldo

Research output: Contribution to journalComment/debate

Abstract

Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years.

Original languageEnglish
Pages (from-to)744-747
Number of pages4
JournalInternational Journal of Clinical Pharmacy
Volume40
Issue number4
DOIs
Publication statusPublished - Aug 1 2018

    Fingerprint

Keywords

  • Adverse drug reactions
  • History
  • Legislation
  • Pharmacovigilances
  • Signal detection
  • Thalidomide

ASJC Scopus subject areas

  • Pharmacy
  • Toxicology
  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this